by Shelly Lundahl | Aug 12, 2026 | News, Thought Leadership
3 Shifts to Close the Gap Innovation teams have more data, better tools, and faster access to consumers than ever before. And products are still missing the mark. At Quirk’s New York, we took the stage and named the real reason: what research is being designed...
by Shelly Lundahl | May 20, 2026 | News, Thought Leadership
GLP-1 medications aren’t just suppressing appetites. They’re dismantling the business models the food industry was built on. With 12% of U.S. adults now using GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound—and adoption projected to reach 30–50...
by Shelly Lundahl | Mar 11, 2026 | News, Thought Leadership
AI is the new baseline. But how can you move beyond it? AI tools like Copilot are rapidly becoming embedded in everyday workflows. Most teams are already experimenting with GenAI; access to these tools no longer automatically translates into better outcomes or gaining...
by Shelly Lundahl | Dec 3, 2025 | BehaviorLens, Thought Leadership
Five Steps for the AI-Driven Insights Leader Innovation is rarely a straight line. For leaders in consumer goods, pharma, and food & beverage, the journey from idea to market is often complicated by silos, shifting consumer behaviors, and the challenge of aligning...
by Dave Lundahl | May 13, 2025 | News, Thought Leadership
Making Taste with Intention Part One: Is Food Too Enjoyable? Byline Dave Lundahl, Founder & CEO at InsightsNow In recent years, we’ve seen the dramatic rise of GLP-1 drug users – originally designed to control blood sugar levels by regulating the GLP-1 hormone in...
by Heather | Oct 25, 2022 | BehaviorLens, Thought Leadership, White Paper
Not only are plant-based meats perceived to be physically healthier by consumers with their low saturated fats and high vegetable content—these alternatives also take into account ethical considerations like animal welfare—and are simply better for the planet from a sustainability standpoint than regular meats.